Full Description
Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases presents recent advances in the vivid molecular pathways targeting angiogenesis, inflammation, and oxidative stress that contribute very widely to the genesis of chronic diseases. The books highlights drugs from natural and synthetic origins in the management/prevention/treatment of diseases, along with the drug delivery approaches. The book's authors from various key institutions around the globe deliver well-structured and designed chapters. The systematic presented information and knowledge will surely aid consistency and continuity. The multifaceted book is enriched with deep scientific content. Each chapter clearly defines the facts, the emerging role of molecular pathways, and targets and focus, along with key challenges and future directions that will provide new areas for researchers to explore new targets in the domain.
Contents
1. Understanding the role of angiogenesis, inflammation and oxidative stress in diabetes mellitus: insights into the past, present and future trends
2. Targeting angiogenesis, inflammation, and oxidative stress in obesity
3. Molecular role of angiogenesis, inflammation and oxidative stress in cancer
4. Rheumatoid arthritis: Its etiology, pathophysiology, and treatment
5. Inflammatory bowel diseases (IBDs)
6. Natural and synthetic agents targeting angiogenesis, oxidative stress, and inflammation in psoriasis
7. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives
8. Decrypting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure
9. Expatiating the role of angiogenesis, inflammation and oxidative stress in angina pectoris: A state-of-the-art on the drug delivery approaches
10. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's siseases
11. Advancement in herbal drugs for the treatment of Parkinson's disease
12. Targeting angiogenesis, inflammation, and oxidative stress in depression
13. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy
14. Diabetic retinopathy: Stressing the function of angiogenesis, inflammation and oxidative stress in the disease
15. Targeting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of glaucoma: Strategic nanotechnology based drug delivery approaches
16. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches
17. Intricate the potential role of nanotechnology as cutting-edge for management of hirsutism and gynecosmatia: A paradigm in therapeutics
18. Role of angiogenesis, inflammation and oxidative stress in polycystic ovary syndrome (PCOS): Current perspectives
